Immunohistochemical Algorithm for the Diagnosis and Classification of Hepatocellular Carcinomas With TERT, TP53 and CTNNB1 Mutation

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

May 13, 2025

Study Completion Date

June 30, 2025

Conditions
Hepatic CancerHepatic Resection
Interventions
DIAGNOSTIC_TEST

Immunohistochemistry and in situ hybridisation analysis

immunohistochemistry and in situ hybridisation analysis for several markers, including p53, beta-Catenin and albumin, but also markers considered diagnostic for HCC such as Glutamin Synthetase, Glypican-3 and HSP70, to identify a more rational diagnostic-prognostic algorithm for primary liver lesions.

Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER